Dr. Serels is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12 Elmcrest Ter
Norwalk, CT 06850Phone+1 203-853-4200Fax+1 203-299-1938
Education & Training
- Cleveland Clinic FoundationFellowship, Female Pelvic Medicine And Reconstructive Surgery (Urology), 1998 - 1999
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Urology, 1994 - 1998
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 1992 - 1994
- New York University School of MedicineClass of 1992
Certifications & Licensure
- CT State Medical License 1999 - 2025
- NY State Medical License 1993 - 2025
- FL State Medical License 2018 - 2020
- OH State Medical License 1998 - 2000
- American Board of Urology Urology
- American Board of Urology Female Pelvic Medicine and Reconstructive Surgery
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Top MD Consumers Checkbook
Clinical Trials
- Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence Start of enrollment: 2013 Jun 01
- Uphold LITE Post-Market Surveillance Study Start of enrollment: 2013 Oct 10
- Solace Stress Urinary inContinence Control Efficacy and Safety Study Start of enrollment: 2014 Aug 11
Publications & Presentations
PubMed
- 23 citationsEffectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive b...Rodney U. Anderson, Scott MacDiarmid, Sherron Kell, James H. Barada, Scott Serels
International Urogynecology Journal and Pelvic Floor Dysfunction. 2006-05-03 - 62 citationsTreatment with solifenacin increases warning time and improves symptoms of overactive bladder: results from VENUS, a randomized, double-blind, placebo-controlled trial.Mickey M. Karram, Marc R. Toglia, Scott Serels, Masakazu Andoh, Allam Fakhoury
Urology. 2009-01-01 - 18 citationsSolifenacin for overactive bladder: patient-reported outcomes from a large placebo-controlled trial.Marc R. Toglia, Scott Serels, Christine Laramée, Mickey M. Karram, Indrani Nandy
Postgraduate Medicine. 2009-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: